Ovarian Cancer

Phenoxodiol—A Chemosensitizer

Phenoxodiol—A Chemosensitizer

Phenoxodiol—A Chemosensitizer in the Midst of Cancer Chemoresistance

Ayesha B Alvaro, Patricia Rossi , David Brown, Aliza Leiser, Thomas Rutherford, Alan Husband, Gil Mor

US Oncological Review, 2008;4(1):39-41

Advanced Ovarian Cancer

First-line Chemotherapy

First-line Chemotherapy

First-line Chemotherapy in Patients with Advanced Ovarian Cancer

Dirk Olaf Bauerschlag, Felix Hilpert, Ivo Meinhold-Heerlein, Walter Jonat, Jacobus Pfisterer

European Oncological Disease, 2007;1(2):90-1

Epithelial Ovarian Cancer

Epithelial Ovarian Cancer

Maternal Epithelial Ovarian Cancer

Julia Palmer, John Tidy, Manu Vatish

European Oncology, 2009;5(1):64-6

Editor's choice

Ovarian Cancer
Maternal Epithelial Ovarian Cancer
Julia Palmer et al.
European Oncology & Haematology, 2009;5(1):64-6

Also in Editor's Choice

Topotecan Weekly versus Topotecan Five-day Schedule in Patients with Platinum-resistant Ovarian Cancer – Which Is the Best Regimen?
Defining Optimal Treatment in Early-stage Epithelial Ovarian Cancer – When, What and for How Long?
First-line Chemotherapy in Patients with Advanced Ovarian Cancer

Latest Articles

Long-term Survival Advantage for Recurrent Ovarian Cancer Patients Receiving Pegylated Liposomal Doxorubicin
Alan N Gordon
all articles >
close

This content is copyright protected

However, if you would like to share the information on this webpage, you may use the headline and link below:

Ovarian Cancer

Read more: Ovarian Cancer